URINARY BLADDER NEOPLASM
Clinical trials for URINARY BLADDER NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new URINARY BLADDER NEOPLASM trials appear
Sign up with your email to follow new studies for URINARY BLADDER NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug shows promise in early trial
Disease control OngoingThis early-stage trial tests a new drug called LY4101174 in people with advanced solid tumors, including bladder, breast, and lung cancers. The drug is an antibody-drug conjugate designed to target and kill cancer cells. The study will check if the drug is safe, tolerable, and ef…
Matched conditions: URINARY BLADDER NEOPLASM
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New drug BT8009 targets Hard-to-Treat cancers in early trial
Disease control OngoingThis study tests a new drug called BT8009, alone or with another drug (pembrolizumab), in people with advanced solid tumors like bladder, breast, lung, or ovarian cancer. The drug targets a protein called Nectin-4 found on some cancer cells. The trial aims to find safe doses and …
Matched conditions: URINARY BLADDER NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: BicycleTx Limited • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC